| Literature DB >> 32384648 |
Alexandra Matei1, Cringu Ionescu1, Florin Gorun2, Diana Gheorghiu3, George-Alexandru Rosu1, Adelina Dan1, Romina-Marina Sima1, Cristian George Furau4, Corina Ilinca5, Dan Navolan2.
Abstract
Hysteroscopy has known an increasing use in Romania over the last decade, succeeding to mark an impact on lowering the costs of medical services. The strategy of this study was to present the experience of two Romanian medical units with different experiences using inpatient regimen hysteroscopy, and to further compare it with current worldwide tendencies. Strong points in our practice were sought, as well as components that require improvement. Overall, abnormal uterine bleeding stands for most hospital case presentations in our study group; hysteroscopy had the highest accuracy and positive predictive value in identifying uterine myomas: 91.03% and 100%, respectively; for endometrial polyps, statistical analysis showed the highest sensitivity: 100%, with 83.89% specificity and a 77.64% positive predictive value. The applicability of hysteroscopy was further described for infertility cases and isthmocele repair.Entities:
Keywords: endometrial hyperplasia; hysteroscopy; infertility; isthmocele; myoma
Year: 2020 PMID: 32384648 PMCID: PMC7278013 DOI: 10.3390/diagnostics10050281
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Descriptive statistics of patient age, area of residence and menopausal status.
| Total | Bucharest | Timișoara | |
|---|---|---|---|
| Average age (years) | 41 | 39 | 41 |
| Min (years) | 20 | 20 | 22 |
| Max (years) | 76 | 63 | 76 |
| Area of residence | |||
| Rural | 33.05% | 11.11% | 36.2% |
| Urban | 66.95% | 88.88% | 63.8% |
| Menopausal status | |||
| Menopause | 17.67% | 4.44 % | 19.55% |
| Reproductive age | 82.33% | 95.56% | 80.45% |
Figure 1Patient distribution according to age groups.
Indications for hysteroscopy.
| Total 1 | Bucharest | Timișoara | |
|---|---|---|---|
| ( | ( | ( | |
| IUD retention 2 | 19 (5.16%) | 0 (0.00%) | 19 (5.88%) |
| AUB 3 | 131 (35.59%) | 36 (80.00%) | 95 (29.41%) |
| Postmenopausal | 15 (4.07%) | 1 (2.22%) | 14 (4.33%) |
| Endometrial thickening | 41 (11.14%) | 7 (15.55%) | 34 (10.52%) |
| Hypertrophy | 17 (4.61%) | 0 (0.00%) | 17 (5.26%) |
| Hyperplasia | 24 (6.52%) | 7 (15.55%) | 17 (5.26%) |
| Uterine myoma | 55 (14.94%) | 18 (40.00%) | 37 (11.45%) |
| Intracavitary | 19 (5.16%) | 1 (2.22%) | 18 (5.57%) |
| Chronic pelvic pain | 11 (2.98%) | 3 (6.66%) | 8 (2.47%) |
| Adenomyosis | 6 (1.63%) | 2 (4.44%) | 4 (1.23%) |
| Infertility | 68 (18.47%) | 7 (15.55%) | 61 (18.88%) |
| primary | 36 (9.78%) | 2 (4.44%) | 34 (10.52%) |
| secondary | 25 (6.79%) | 5 (11.11%) | 20 (6.19%) |
| Uterine septum | 3 (0.81%) | 0 (0.00%) | 3 (0.92%) |
| Polyps | 153 (41.57%) | 25 (55.55%) | 128 (39.62%) |
| Cervical polyp | 12 (3.26%) | 4 (8.88%) | 8 (2.47%) |
| Endometrial polyp | 140 (38.04%) | 21 (46.66%) | 119 (36.84%) |
| Isthmocele | 2 (0.54%) | 0 (0.00%) | 2 (0.61%) |
1 Data are presented as N (%); 2 IUD: intrauterine device; 3 AUB: abnormal uterine bleeding.
Hysteroscopic diagnoses by hospital (number of cases).
| Total 1 | Bucharest | Timișoara | |
|---|---|---|---|
| ( | ( | ( | |
| IUD retention 2 | 16 (4.34%) | 0 (0.00%) | 16 (4.95%) |
| Endometrial thickening | 63 (17.11%) | 16 (35.55%) | 47 (14.55%) |
| Hypertrophy | 28 (7.60%) | 3 (6.66%) | 25 (7.73%) |
| Hyperplasia | 32 (8.69%) | 11 (24.44%) | 21 (6.50%) |
| Neoplasia | 1 (0.27%) | 0 (0.00%) | 1 (0.30%) |
| Uterine myoma | 43 (11.68%) | 6 (13.33%) | 37 (11.45%) |
| Intracavitary myoma | 19 (5.16%) | 3 (6.66%) | 16 (4.95%) |
| Adenomyosis | 2 (0.54%) | 2 (4.44%) | 0 (0.00%) |
| Uterine septum | 3 (0.81%) | 0 (0.00%) | 3 (0.92%) |
| Synechia | 34 (9.23%) | 0 (0.00%) | 34 (10.52%) |
| Uterine | 26 (7.06%) | 0 (0.00%) | 26 (8.04%) |
| Cervical | 8 (2.17%) | 0 (0.00%) | 8 (2.47%) |
| Polyp | 186 (50.54%) | 21 (46.66%) | 165 (51.08%) |
| Cervical | 16 (4.34%) | 4 (8.88%%) | 12 (3.71%) |
| Endometrial | 170 (46.19%) | 17 (37.77%) | 153 (47.36%) |
| Isthmocele | 1 (0.27%) | 0 (0.00%) | 1 (0.30%) |
| Normal uterine cavity | 34 (9.23%) | 1 (2.22%) | 33 (10.21%) |
1 Data are presented as N (%); 2 IUD: intrauterine device.
Hysteroscopic procedures by hospital (number of cases).
| Total 1 | Bucharest | Timișoara | |
|---|---|---|---|
| ( | ( | ( | |
| Diagnostic hysteroscopy | 338 (91.84%) | 25 (55.55%) | 313 (96.90%) |
| Uterine curettage | 97 (26.35%) | 23 (51.11%) | 74 (22.91%) |
| Endometrial biopsy | 14 (3.80%) | 8 (17.77%) | 6 (1.85%) |
| Endometrial resection | 13 (3.53%) | 0 (0.00%) | 13 (4.02%) |
| Endometrial ablation | 3 (0.81%) | 0 (0.00%) | 3 (0.92%) |
| Excision of polyps | 161 (43.75%) | 17 (37.77%) | 144 (44.58%) |
| Fibroid resection | 25 (6.79%) | 1 (2.22%) | 24 (7.43%) |
| Uterine synechia lysis | 7 (1.90%) | 1 (2.22%) | 6 (1.85%) |
| IUD extraction 2 | 16 (4.34%) | 0 (0.00%) | 16 (4.95%) |
| IUD insertion 2 | 2 (0.54%) | 0 (0.00%) | 2 (0.61%) |
| Isthmocele repair | 1 (0.27%) | 0 (0.00%) | 1 (0.30%) |
1 Data are presented as N (%); 2 IUD: intrauterine device.
Figure 2Main hysteroscopic procedures in the two centers. Data are presented as N.
Histopathological diagnoses by hospital (number of cases).
| Total | Bucharest | Timișoara | |
|---|---|---|---|
| ( | ( | ( | |
| Endometritis | 17 (4.61%) | 10 (22.22%) | 7 (2.16%) |
| Secretory endometrium | 11 (2.98%) | 7 (15.55%) | 4 (1.23%) |
| Proliferative endometrium | 24 (6.52%) | 5 (11.11%) | 19 (5.88%) |
| Simple endometrial hyperplasia | 156 (42.39%) | 3 (6.66%) | 153 (47.36%) |
| without atypia | 49 (13.31%) | 1 (2.22%) | 48 (14.86%) |
| with atypia | 3 (0.81%) | 0 (0.00%) | 3 (0.92%) |
| not specified | 104 (28.26%) | 2 (4.44%) | 102 (31.57%) |
| Complex endometrial hyperplasia | 43 (11.68%) | 0 (0.00%) | 43 (13.31%) |
| without atypia | 12 (3.26%) | 0 (0.00%) | 12 (3.71%) |
| with atypia | 10 (2.71%) | 0 (0.00%) | 10 (3.09%) |
| not specified | 21 (5.70%) | 0 (0.00%) | 21 (6.50%) |
| Cervicitis | 14 (3.80%) | 3 (6.66%) | 11 (3.40%) |
| Polyps | 139 (37.77%) | 21 (46.66%) | 118 (36.53%) |
| Cervical polyp | 7 (1.90%) | 2 (4.44%) | 5 (1.54%) |
| Endometrial polyp | 132 (35.86%) | 19 (42.22%) | 113 (34.98%) |
| Uterine myoma | 76 (20.65%) | 5 (11.11%) | 71 (21.98%) |
| Adenomyosis | 26 (7.06%) | 0 (0.00%) | 26 (8.04%) |
| Endometrial neoplasm | 7 (1.90%) | 1 (2.22%) | 6 (1.85%) |
| Cervical neoplasm | 4 (1.08%) | 0 (0.00%) | 4 (1.23%) |
| Choriocarcinoma | 1 (0.27%) | 0 (0.00%) | 1 (0.30%) |
Figure 3Distribution of patients with histopathological identified neoplasms according to age.
Figure 4Neoplasia histopathological diagnoses distribution on patient background. Data are presented as N.
Figure 5Comparison between clinical, hysteroscopic and histopathological diagnoses in each center and total evaluation for: (a) endometrial polyp; (b) uterine myoma; (c) endometrial hyperplasia. Data are presented as N.
Figure 6Simple (Series 1) and complex (Series 2) endometrial hyperplasia histopathological (HP) diagnosis distribution, according to patient age
Figure 7Simple (SHA) and complex (CHA) endometrial hyperplasia with atypia histopathologic diagnosis distribution, according to patient age